Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Angion Biomedica Corp. ANGN
$0.78
-$0.01 (-1.77%)
На 18:04, 12 мая 2023
+92.31%
Потенциал через год
Ранг: 3
Ключевые показатели
-
Marketcap
24091360.00000000
-
week52high
2.04
-
week52low
0.46
-
Revenue
2301000
-
P/E TTM
0
-
Beta
0.54321400
-
EPS
-1.15000000
-
Last Dividend
0.00000000
-
Next Earnings Date
15 мая 2023 г. в 10:59
Описание компании
Angion Biomedica Corp., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapeutics for acute organ injuries and fibrotic diseases. The company's lead product candidate is ANG-3070, an oral tyrosine kinase receptor inhibitor in development as a treatment for fibrotic diseases, primarily in the kidney and lung. It also develops ANG-3777, a hepatocyte growth factor mimetic to treat acute organ injuries, such as delayed graft function; ROCK2 inhibitors programs for fibrotic diseases; and CYP11B2 inhibitor program. The company was incorporated in 1998 and is based in Uniondale, New York.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| HC Wainwright & Co. | Neutral | Buy | 18 июл 2022 г. |
| Stifel | Hold | Buy | 30 июн 2022 г. |
| Oppenheimer | Perform | Outperform | 30 июн 2022 г. |
| HC Wainwright & Co. | Buy | Buy | 23 мая 2022 г. |
| HC Wainwright & Co. | Buy | Buy | 18 апр 2022 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Goldberg Itzhak | D | 1687986 | 32082 | 01 июл 2022 г. |
| OMENN GILBERT S | A | 15000 | 15000 | 09 июн 2022 г. |
| WILSON KAREN J | A | 15000 | 15000 | 09 июн 2022 г. |
| Nissenson Allen | A | 15000 | 15000 | 09 июн 2022 г. |
| GANZI VICTOR F | A | 15000 | 15000 | 09 июн 2022 г. |
| Venkatesan Jay | A | 1891947 | 11313 | 25 мая 2022 г. |
| Venkatesan Jay | A | 1721457 | 32200 | 24 мая 2022 г. |
| Venkatesan Jay | A | 1689257 | 50000 | 20 мая 2022 г. |
| Nissenson Allen | A | 9383 | 2037 | 20 мая 2022 г. |
| Nissenson Allen | A | 7346 | 7346 | 19 мая 2022 г. |
Новостная лента
Angion (ANGN) Down on Merger Agreement With Private Biotech
Zacks Investment Research
18 янв 2023 г. в 14:18
Angion (ANGN) inks a definitive merger agreement with privately-held Elicio Therapeutics. The combined company's lead pipeline candidate will be ELI-002, a therapeutic cancer vaccine targeting mKRAS-driven tumors.
New Strong Buy Stocks for November 16th
Zacks Investment Research
16 ноя 2022 г. в 09:02
ENTX, STIM, FN, ANGN and FUTU have been added to the Zacks Rank #1 (Strong Buy) List on November 16, 2022.
New Strong Buy Stocks for October 25th
Zacks Investment Research
25 окт 2022 г. в 09:02
PHX, BEPC, ANGN, CXM and GMBL have been added to the Zacks Rank #1 (Strong Buy) List on October 25, 2022.
Angion Biomedica Pulls The Plug On Another Kidney Disease Trial - Read Why
Benzinga
30 июн 2022 г. в 06:11
Angion Biomedica Corp (NASDAQ: ANGN) has discontinued the JUNIPER Phase 2 trial of ANG-3070, an oral tyrosine kinase inhibitor, in primary proteinuric kidney diseases, specifically focal segmental glomerulosclerosis and immunoglobulin A nephropathy. The trial began enrolling.
What to Know About Buying Penny Stocks on June 1st
PennyStocks
01 июн 2022 г. в 07:00
Here's what you need to know about trading penny stocks on June 1st The post What to Know About Buying Penny Stocks on June 1st appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.